Mayer N Fishman

Summary

Affiliation: University of South Florida
Country: USA

Publications

  1. ncbi request reprint Novel therapies for renal cell carcinoma--an update
    Mayer Fishman
    H Lee Moffitt Cancer Center and Research Institute, University of South Florida, MCC 4035, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Expert Opin Investig Drugs 12:593-609. 2003
  2. ncbi request reprint Cell-based immune therapy for metastatic renal cancer
    Mayer N Fishman
    Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center, University of South Florida, Tampa 33612, USA
    Expert Rev Anticancer Ther 3:837-49. 2003
  3. ncbi request reprint Specific antitumour vaccine for renal cancer
    Mayer Fishman
    Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Lancet 363:583-4. 2004
  4. ncbi request reprint Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy
    Kamran Zargar-Shoshtari
    Department of Genitourinary Oncology, Moffitt Cancer Center, 12902 Magnolia Dr, Tampa, FL, 33612, USA
    World J Urol 34:1567-1573. 2016
  5. pmc Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison
    Brian D Gonzalez
    Brian D Gonzalez, Heather S L Jim, Margaret Booth Jones, Steven K Sutton, Hui Yi Lin, Jong Y Park, Philippe E Spiess, Mayer N Fishman, and Paul B Jacobsen, Moffitt Cancer Center and Brent J Small, University of South Florida, Tampa, FL
    J Clin Oncol 33:2021-7. 2015
  6. pmc Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison
    Ashley M Nelson
    Department of Health Outcomes and Behavior, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA
    Support Care Cancer 24:4159-66. 2016
  7. ncbi request reprint Immunotherapy of metastatic renal cell cancer
    Mayer Fishman
    Genitourinary Oncology Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 9:293-304. 2002
  8. ncbi request reprint Increased bioavailability of intravenous versus oral CI-1033, a pan erbB tyrosine kinase inhibitor: results of a phase I pharmacokinetic study
    George R Simon
    Division of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    Clin Cancer Res 12:4645-51. 2006
  9. ncbi request reprint Cytoreductive nephrectomy vs medical therapy as initial treatment: a rational approach to the sequence question in metastatic renal cell carcinoma
    Philippe E Spiess
    Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Cancer Control 17:269-78. 2010
  10. ncbi request reprint Targeted therapy of kidney cancer: keeping the art around the algorithms
    Mayer N Fishman
    Genitourinary Oncology Program, Moffitt Cancer Center, Tampa, FL 33612, USA
    Cancer Control 20:222-32. 2013

Collaborators

Detail Information

Publications21

  1. ncbi request reprint Novel therapies for renal cell carcinoma--an update
    Mayer Fishman
    H Lee Moffitt Cancer Center and Research Institute, University of South Florida, MCC 4035, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Expert Opin Investig Drugs 12:593-609. 2003
    ..Although high percentage improvements in outcomes for metastatic RCC are not yet realised, the many fronts for scientific and clinical advances form some basis for optimism in the coming years...
  2. ncbi request reprint Cell-based immune therapy for metastatic renal cancer
    Mayer N Fishman
    Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center, University of South Florida, Tampa 33612, USA
    Expert Rev Anticancer Ther 3:837-49. 2003
    ..Broad efforts with innovative treatments may portend real progress for metastatic renal cancer immunotherapy...
  3. ncbi request reprint Specific antitumour vaccine for renal cancer
    Mayer Fishman
    Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Lancet 363:583-4. 2004
  4. ncbi request reprint Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy
    Kamran Zargar-Shoshtari
    Department of Genitourinary Oncology, Moffitt Cancer Center, 12902 Magnolia Dr, Tampa, FL, 33612, USA
    World J Urol 34:1567-1573. 2016
    ..The aim of this study was to describe outcomes associated with the use of adjuvant chemotherapy (AC) in patients with residual non-organ confined cancer at RC following NAC...
  5. pmc Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison
    Brian D Gonzalez
    Brian D Gonzalez, Heather S L Jim, Margaret Booth Jones, Steven K Sutton, Hui Yi Lin, Jong Y Park, Philippe E Spiess, Mayer N Fishman, and Paul B Jacobsen, Moffitt Cancer Center and Brent J Small, University of South Florida, Tampa, FL
    J Clin Oncol 33:2021-7. 2015
    ..Our study examined the impact of ADT on impaired cognitive performance and explored potential demographic and genetic predictors of impaired performance...
  6. pmc Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison
    Ashley M Nelson
    Department of Health Outcomes and Behavior, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL, 33612, USA
    Support Care Cancer 24:4159-66. 2016
    ..The present study examined changes in fatigue among prostate cancer patients receiving ADT compared to controls and predictors of heightened fatigue in ADT patients...
  7. ncbi request reprint Immunotherapy of metastatic renal cell cancer
    Mayer Fishman
    Genitourinary Oncology Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 9:293-304. 2002
    ..The management of metastatic renal cancer remains a therapeutic challenge. Conventional cytotoxic chemotherapy is rarely effective, and the most promising approaches appear to lie in the field of immunotherapy...
  8. ncbi request reprint Increased bioavailability of intravenous versus oral CI-1033, a pan erbB tyrosine kinase inhibitor: results of a phase I pharmacokinetic study
    George R Simon
    Division of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    Clin Cancer Res 12:4645-51. 2006
    ..In phase I studies with oral CI-1033, dose-limiting toxicities were primarily gastrointestinal, supporting the exploration of i.v. dosing to achieve optimal drug exposures by increasing bioavailability...
  9. ncbi request reprint Cytoreductive nephrectomy vs medical therapy as initial treatment: a rational approach to the sequence question in metastatic renal cell carcinoma
    Philippe E Spiess
    Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Cancer Control 17:269-78. 2010
    ..Renal cell carcinoma (RCC) can be considered as two distinct entities: localized and metastatic disease...
  10. ncbi request reprint Targeted therapy of kidney cancer: keeping the art around the algorithms
    Mayer N Fishman
    Genitourinary Oncology Program, Moffitt Cancer Center, Tampa, FL 33612, USA
    Cancer Control 20:222-32. 2013
    ..Interferon and interleukin 2 also are part of the treatment algorithms...
  11. ncbi request reprint Growing opportunities for adjuvant therapy of renal cell carcinoma: targeted drugs and vaccines
    Alejandro R Rodriguez
    University of South Florida, Department of Interdisciplinary Oncology, Division of Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, Florida 33612 9497, USA
    Expert Opin Pharmacother 8:2979-90. 2007
    ..These new agents may lead to opportunities to improvement of disease-free survival through therapy in the adjuvant setting...
  12. ncbi request reprint Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma
    Mayer Fishman
    H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA
    J Immunother 31:72-80. 2008
    ..Better outcomes could be logically associated to vaccine response (detectable lymphocytic infiltrates) or to random events that a single arm study design cannot address. This vaccine approach may merit further clinical development...
  13. ncbi request reprint Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma
    Pranav Sharma
    Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida, USA
    Can J Urol 22:7882-9. 2015
    ..We present our experience with minimally-invasive retroperitoneal lymph node dissection (MI-RPLND) in the post-chemotherapy (PC) setting for residual masses in patients with nonseminoma...
  14. pmc Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison
    Brian D Gonzalez
    Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, Florida Supportive Care Medicine, Moffitt Cancer Center, Tampa, Florida Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida School of Aging Studies, University of South Florida, Tampa, Florida
    J Urol 194:690-5. 2015
    ..We also examined demographic, clinical and genetic predictors of the impact of androgen deprivation therapy on hot flash interference...
  15. doi request reprint Surgery plus targeted therapy for renal cell carcinoma with isolated spermatic cord metastasis
    Jose J Correa
    Department of Urologic Oncology and Genitourinary Medical Oncology, H Lee Moffitt Cancer and Research Center, Tampa, FL 33612, USA
    Clin Genitourin Cancer 7:E101-3. 2009
    ..We present a case of renal cell carcinoma with metastasis to the ipsilateral spermatic cord. We report the clinical presentation and management of this case and review the scientific literature of this unusual case presentation...
  16. pmc All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
    Noweeda Mirza
    H Lee Moffitt Cancer Center and the Department of Interdisciplinary Oncology, University of South Florida, Tampa, Florida 33612, USA
    Cancer Res 66:9299-307. 2006
    ..ATRA treatment did not result in significant toxicity and it could be tested in therapeutic combination with cancer vaccines...
  17. ncbi request reprint Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial
    George R Simon
    Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, SRB 2, Tampa, 33612 9416, USA
    Mol Cancer Ther 5:2130-7. 2006
    ..Here, we evaluated a sequence-specific administration of a topo I inhibitor followed by a topo II inhibitor...
  18. ncbi request reprint Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study
    Pamela Munster
    Experimental Therapeutics, Breast Medical Oncology Program, Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center, Tampa, FL 33612, USA
    J Clin Oncol 25:1979-85. 2007
    ....
  19. doi request reprint A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer
    Mayer Fishman
    Moffitt Cancer Center, Department of Genitourinary Oncology, Tampa, FL 33612, USA
    Expert Opin Biol Ther 9:1565-75. 2009
    ..More recently DCvax brain, a product using a similar DC platform showed encouraging Phase I-II results and sipleucel-T, a prostatic acid phosphatase (PAP)-directed DC immunotherapy had positive Phase III results...
  20. pmc Lipid accumulation and dendritic cell dysfunction in cancer
    Donna L Herber
    Department of Immunology, H Lee Moffitt Cancer Center, Tampa, Florida, USA
    Nat Med 16:880-6. 2010
    ..These findings suggest that immune responses in cancer can be improved by manipulating the lipid levels in DCs...
  21. ncbi request reprint Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
    Yulia Nefedova
    H Lee Moffitt Cancer Center and University of South Florida, Tampa, Florida 33612, USA
    Cancer Res 67:11021-8. 2007
    ..This novel mechanism involves specific up-regulation of GSS and accumulation of GSH and could be used in developing and monitoring therapeutic application of ATRA...